Enanta Pharmaceuticals, Inc.盘中异动大幅跳水5.08%

市场透视10-23

北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.（ENTA.us）股票出现异动，股价急速下挫5.08%。截至发稿，该股报12.34美元/股，成交量2.6207万股，换手率0.12%，振幅7.77%。最近的财报数据显示，该股实现营业收入17.97百万美元，净利润-22.66百万美元，每股收益-1.07美元，毛利17.38百万美元，市盈率-2.27倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477953620?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-23 22:07","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477953620","market":"us","top_or_hot":-1,"title":"Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.08%","media":"市场透视","content":"<div>\n<p>北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.（ENTA.us）股票出现异动，股价急速下挫5.08%。截至发稿，该股报12.34美元/股，成交量2.6207万股，换手率0.12%，振幅7.77%。最近的财报数据显示，该股实现营业收入17.97百万美元，净利润-22.66百万美元，每股收益-1.07美元，毛利17.38百万美元，市盈率-2.27倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.08%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.08%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-23 22:07 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.（ENTA.us）股票出现异动，股价急速下挫5.08%。截至发稿，该股报12.34美元/股，成交量2.6207万股，换手率0.12%，振幅7.77%。最近的财报数据显示，该股实现营业收入17.97百万美元，净利润-22.66百万美元，每股收益-1.07美元，毛利17.38百万美元，市盈率-2.27倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ENTA","symbol_name":"Enanta Pharmaceuticals Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b","article_id":"2477953620","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477953620","pubTimestamp":1729692430,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.08%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1497.14%、762.48%、330.05%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为71.86%、68.32%、64.38%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ENTA":"Enanta Pharmaceuticals Inc.","BK4139":"生物科技"},"translate_title":"Enanta Pharmaceuticals, Inc. plunged 5.08% during the session","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ENTA":0.9},"content_text":"北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.（ENTA.us）股票出现异动，股价急速下挫5.08%。截至发稿，该股报12.34美元/股，成交量2.6207万股，换手率0.12%，振幅7.77%。最近的财报数据显示，该股实现营业收入17.97百万美元，净利润-22.66百万美元，每股收益-1.07美元，毛利17.38百万美元，市盈率-2.27倍。机构评级方面，在所有8家参与评级的机构中，50%的券商给予买入建议，38%的券商给予持有建议，12%的券商给予卖出建议。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1497.14%、762.48%、330.05%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)，振幅分别为71.86%、68.32%、64.38%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。该公司主要针对的疾病包括丙型肝炎、乙型肝炎、非酒精性脂肪型肝炎和呼吸道合胞病毒。公司研发的新颖之处在于一种用于治疗丙型肝炎病毒的特异性直接作用抗病毒抑制剂。该公司的抑制剂是与 AbbVie 合作开发的。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477953620"}

Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.08%

精彩评论

Enanta Pharmaceuticals, Inc.盘中异动大幅跳水5.08%